Abstract Details

Title A review of the drug–drug interactions of the new antiepileptic drug brivaracetam

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P4 - (-)

Poster/Presentation
Number 109

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Brian D. Moseley, MD PRESENTER	Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����